• The New York Post reports that “big-box retailers aren’t selling CBD yet, but they’re busy getting ready for the day when they can … top executives at major chains such as Walmart and Target have been quietly meeting with makers of drinks, gummy bears, topical creams and oils that are infused with cannabidiol, or CBD … The chains, which also include big supermarkets such as Kroger and Safeway, are requesting samples of CBD products, along with lab results and pricing information, manufacturers said.”

CBD is the non-psychoactive compound in cannabis.

This interest, the Post notes, is “despite the fact that the Food and Drug Administration said in December that it’s illegal to spike food and beverages with CBD or THC … or to transport them over state lines.”


• Nielsen is out with new cannabis-centric research, finding that “34% of U.S. adults (age 21+) are interested in consuming legalized cannabis … Among U.S. adults (age 21+) who report they would likely consume cannabis if it were legally available, the top reasons are all tied to ailment treatment, prevention and general wellness.”

The study goes on: “For some needs and ailments, consumers may actually prefer products derived from marijuana, which can only be sold in licensed recreational or medicinal dispensaries. In other instances, consumers might prefer CBD products derived from hemp, which have been federally de-scheduled and are gradually making their way into major retail chains.”

Some other data from the study: “A significant percentage of certain ailment sufferers are interested in consuming cannabis: 40% of all headache / migraine pain sufferers, 40% of all arthritic pain sufferers and 41% of all back / neck pain sufferers. And, with a few exceptions, the majority of these cannabis-interested adults currently treat their ailments with OTC/Rx medications.”

And: “Seventy percent of adults who are interested in cannabis and who today treat their ailment with OTC/Rx medications say they would consider treating with cannabis because of the perception that it’s more effective than OTC/Rx alternatives. Sixty-seven percent perceive cannabis to be healthier than OTC/Rx medications, and 69% are influenced by the perception that cannabis is more natural than OTC and Rx alternatives. Just under 50% of adults currently treating an ailment with OTC/Rx medications would consider cannabis as a treatment because they perceive it to be cheaper/more cost effective.”